Cargando…
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
OBJECTIVE: To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for levodopa among new monotherapy users of dopamine agonists and MAO-B inhibitors. M...
Autores principales: | Binde, Caroline D., Tvete, Ingunn F., Klemp, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270692/ https://www.ncbi.nlm.nih.gov/pubmed/34306611 http://dx.doi.org/10.1155/2021/9952743 |
Ejemplares similares
-
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020) -
Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
por: Krishna, Rakhee, et al.
Publicado: (2014) -
Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
por: Tvete, Ingunn Fride, et al.
Publicado: (2015) -
Correction: Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
por: Tvete, Ingunn Fride, et al.
Publicado: (2016) -
Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
por: Zhang, Jinglin, et al.
Publicado: (2016)